Skip to content
Governance Register

← US public companies

Generex Biotechnology Corp

SEC CIK 1059784 · GNTB · last insider filing 2019-09-11

Directors (from insider filings)

NameCapacity as filedFilings
Prioletti Mark Joseph SE Director filed 2019 - 2019
Salvo Lawrence Anthony Sr Director filed 2019 - 2019
Fletcher Mark Director · VP & General Counsel filed 2007 - 2018
Mcgee Brian Director filed 2006 - 2018
Anderson James H Jr. Director filed 2011 - 2018
Purcell Richard David Jr. Director · SVP of Research & Drug Develop filed 2018 - 2018
Lyman Gary Herbert Director filed 2018 - 2018
Centofanti Kevin Director filed 2018 - 2018
Ro Andrew Director · SVP & Chief Investment Officer filed 2018 - 2018
Von Hofe Eric Director · President of Subsidiary filed 2011 - 2016
Barratt John P Director filed 2006 - 2015
Masterson Nola E Director filed 2007 - 2012
Perri Rose C Director · COO, CFO, Treas. & Secy. filed 2007 - 2011
Gluskin Anna E Director · President & CEO filed 2007 - 2010
Bernstein Gerald Director · VP, Medical Affairs filed 2006 - 2010
Allport Settle Mindy J Director filed 2006 - 2006
Amanatides Peter Director filed 2006 - 2006
Wires David E Director filed 2006 - 2006

Officers (from insider filings)

NameTitle as filedFilings
Corrao Mark CFO & Treasurer filed 2018 - 2018
Brusegard David Chief Operating Officer filed 2011 - 2016
Fellows Stephen Chief Financial Officer filed 2011 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.